Flex Pharma Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Flex Pharma (FLKS) Tops Q2 EPS by 7c
August 2, 2017 7:38 AM EDTFlex Pharma (NASDAQ: FLKS) reported Q2 EPS of ($0.51), $0.07 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $331 thousand versus the consensus estimate of $520 thousand.
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
... More